OverviewSuggest Edit

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure.
Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. The Company's business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering.
TypePublic
Founded1987
HQSan Diego, US
Websiteligand.com
Employee Ratings3

Latest Updates

Employees (est.) (Feb 2019)39
Revenue (FY, 2018)$251.5 M(+79%)
Share Price (Mar 2019)$124.6 (+5%)

Key People/Management at Ligand Pharmaceuticals

John L. Higgins

John L. Higgins

CEO

Ligand Pharmaceuticals Office Locations

Ligand Pharmaceuticals has an office in San Diego
San Diego, US (HQ)
3911 Sorrento Valley Blvd
Show all (1)
Report incorrect company information

Ligand Pharmaceuticals Financials and Metrics

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals's revenue was reported to be $251.45 m in FY, 2018
USD

Revenue (FY, 2018)

251.5m

Net income (FY, 2018)

143.3m

EBIT (FY, 2018)

143.3m

Market capitalization (18-Mar-2019)

2.5b

Closing stock price (18-Mar-2019)

124.6

Cash (31-Dec-2018)

117.2m
Ligand Pharmaceuticals's current market capitalization is $2.5 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

49.0m64.5m71.9m109.0m141.1m251.5m

Revenue growth, %

32%11%52%

Cost of goods sold

5.6m5.4m

Gross profit

103.4m135.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

13.0m16.0m10.6m15.0m14.6m18.4m17.7m29.6m19.5m21.6m29.3m28.0m33.4m56.2m90.0m45.7m

Cost of goods sold

2.5m2.5m1.2m1.5m1.1m955.0k720.0k999.0k341.0k903.0k2.4m788.0k1.1m1.5m

Gross profit

10.5m13.5m9.4m13.5m13.5m28.7m18.8m20.6m28.9m27.1m31.0m55.4m88.9m44.2m

Gross profit Margin, %

80%85%89%90%93%97%96%95%99%97%93%99%99%97%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

11.6m160.2m97.4m18.8m20.6m117.2m

Accounts Receivable

2.2m12.6m6.2m14.7m25.6m55.9m

Inventories

1.4m269.0k1.6m1.9m4.4m7.1m

Current Assets

24.9m185.2m215.6m163.1m237.0m870.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

3.3m13.0m14.5m180.7m165.8m108.2m93.8m31.3m61.4m86.6m10.6m60.2m32.7m51.0m151.5m115.6m

Accounts Receivable

5.5m4.7m3.1m5.8m7.4m5.5m5.5m11.8m10.0m6.6m7.1m13.5m12.8m37.1m42.0m47.0m

Inventories

1.8m1.9m817.0k1.1m2.8m802.0k1.2m1.8m3.8m4.0m7.6m6.8m5.0m10.5m9.5m8.1m

Current Assets

16.6m33.4m28.6m198.5m191.7m196.7m210.3m133.1m126.6m140.7m174.7m197.2m224.2m349.1m1.5b1.7b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

11.4m10.9m254.9m(1.6m)12.6m143.3m

Depreciation and Amortization

2.7m2.7m2.6m11.3m11.7m14.7m

Inventories

646.0k4.4m(401.0k)(244.0k)(843.0k)(2.6m)

Accounts Payable

(2.8m)(4.0m)(2.4m)(1.7m)(4.5m)
Quarterly
USDY, 2018

Financial Leverage

2.2 x
Show all financial metrics
Report incorrect company information

Ligand Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Ligand Pharmaceuticals Blogs

Ligand to Participate in Four Upcoming Investor Conferences

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: Barclays Global Healthcare Conference in Miami. Presentation …

Ligand Provides Highlights from Today’s Analyst Day Event

Webcast available at www.ligand.com SAN DIEGO--(BUSINESS WIRE)-- At an Analyst Day event held today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reviewed the recent progress of its business and financial growth outlook. Management …

Ligand Sells Promacta Assets and Royalty for $827 Million

Updates 2019 full-year financial guidance Conference call with slides to be held today at 5:00 p.m. Eastern time SAN DIEGO & NEW YORK--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Royalty Pharma announce the sale of …

Reminder: Ligand to Host Analyst Day on March 12th in New York City

Event to feature business updates and presentations by four corporate partners SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, March 12, 2019 from 10:00 a.m. to 12:00 p.m. Eastern tim…

Ligand Reports Fourth Quarter and Full Year 2018 Financial Results

Conference Call Begins at 4:30 p.m. Eastern Time TodayAnalyst day to be held on Tuesday March 12 at 10:00 a.m. Eastern Time in New York City SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financ…

Ligand Announces OmniAb® Partnership with Genagon Therapeutics

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb partnership with Genagon Therapeutics AB, an immuno-oncology focused biotech located in Sweden. Under the terms of the partnership, Genagon ga…
Show more

Ligand Pharmaceuticals Frequently Asked Questions

  • When was Ligand Pharmaceuticals founded?

    Ligand Pharmaceuticals was founded in 1987.

  • Who are Ligand Pharmaceuticals key executives?

    Ligand Pharmaceuticals's key executives are John L. Higgins.

  • How many employees does Ligand Pharmaceuticals have?

    Ligand Pharmaceuticals has 39 employees.

  • What is Ligand Pharmaceuticals revenue?

    Latest Ligand Pharmaceuticals annual revenue is $251.5 m.

  • What is Ligand Pharmaceuticals revenue per employee?

    Latest Ligand Pharmaceuticals revenue per employee is $6.4 m.

  • Who are Ligand Pharmaceuticals competitors?

    Competitors of Ligand Pharmaceuticals include Reata Pharmaceuticals, Ironwood Pharmaceuticals and Biogen.

  • Where is Ligand Pharmaceuticals headquarters?

    Ligand Pharmaceuticals headquarters is located at 3911 Sorrento Valley Blvd, San Diego.

  • Where are Ligand Pharmaceuticals offices?

    Ligand Pharmaceuticals has an office in San Diego.

  • How many offices does Ligand Pharmaceuticals have?

    Ligand Pharmaceuticals has 1 office.